Print

---

So Requip is a killer,
 Tasmar is banned in Canada
for somewhat tenuous reasons,
and Sinemet is a poison?

Sounds like a REVOLUTION of
We the People
or We the parkies PWP's
is in order.

The drug companies are
profit-crazy addicts themselves,
 and we the PWP People will
NOT get better-only get
MASKs for the symptoms

Until We the PWP People
UNITE and fight
alongside our caregivers
for a worldwide medication distribution
system free of
pharmaceutical company cartels

Ivan
:-)

On Mon, 14 Feb 2000 23:49:18 -0500 Judith Richards <[log in to unmask]>
writes:
>Canadian doctors are advised to alert patients of "sudden onset of
>sleep" with the anti-Parkinson drug ReQuip (Ropinirole)
>
>OAKVILLE, ON, Feb. 11, 2000/CNW/ - Following consultation with Health
>Canada,
>pharmaceutical manufacturer SmithKline Beecham Pharma is advising
>health
>care professionals, patients and caregivers of important new safety
>information which indicates that ReQuip, a prescription medicine used
>in
>the
>treatment of the signs and symptoms of Parkinson's disease, may cause
>patients to suddenly fall asleep while performing various daily
>activities
>including driving a car.
>
>Sixty cases of sudden onset of sleep have been reported to date,
>world-wide.
>Of these, 10 cases originated in Canada. There have been two fatal
>car
>accidents reported in France. ReQuip has been available in Canada
>since
>August of 1997.
>
>Patients should be advised that sudden sleep has occurred without
>warning
>signs. If drowsiness or sudden sleep should occur, patients should
>immediately contact their physician. Patients are strongly advised
>not
>to
>change the dose or discontinue treatment with ReQuip without the
>recommendation of their doctor.
>
>Until further information is available on the management of this
>unpredictable and serious adverse event, patients who are taking
>ReQuip
>are
>warned not to drive or engage in other activities where impaired
>alertness
>could put themselves and others at risk of serious injury or death
>(e.g.,
>operating machines).
>
>Presently, the precise cause of this adverse event is unknown. What
>is
>known
>is that many patients with Parkinson's disease experience changes in
>their
>sleep patterns, which results in excessive daytime sleepiness or
>spontaneous
>dozing and that some anti-parkinson drugs can also induce sleepiness.
>There is insufficient information to determine whether this adverse
>event is
>associated specifically with ReQuip, some other anti-parkinson drugs,
>or
>Parkinson's disease itself. SmithKline Beecham is currently working
>with
>Health Canada to fully research the potential causes of the sudden
>onset
>of
>sleep.
>
>SmithKline Beecham Pharma is also issuing a letter, to prescribing
>physicians
>and pharmacists which reports this new safety information.
>
>ReQuip is a registered trademark of SmithKline Beecham Pharma
>
>CNW 11-FEB-00
>
>--
>Judith Richards, London, Ontario, Canada
>[log in to unmask]

^^^^^^  WARM GREETINGS  FROM  ^^^^^^^^^^^^  :-)
 Ivan Suzman        50/39/36       [log in to unmask]      :-)
 Portland, Maine    land of lighthouses           deg. F   :-)
********************************************************************